Thus, INSM1 not only serves as a marker of poor differentiation but also represents a functional barrier to RA-mediated maturation, highlighting its potential as a therapeutic target to enhance differentiation-based strategies in high-risk NB. This evidence concerns the gene INSM1 and neuroblastoma.